Prevention of drug toxicities with dichloroacetic acid - The implications for cancer chemotherapy

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1049517

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Many valuable cancer drugs have limited clinical use because of their toxic side effects. Our experiments with a new anti cancer drug called dichloroacetic acid (DCA) will determine if it can reduce the toxic effects of Cisplatin on the kidney and the effects of Doxorubicin on the heart.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $539,839.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Toxicology (incl. Clinical Toxicology)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anthracyclines | cancer chemotherapy | cisplatin | glutathione | nephrotoxicity

Related Links